Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.009 AUD | 0.00% | 0.00% | -62.50% |
May. 24 | The Hydration Pharmaceuticals Postpones Managing Director Appointment | MT |
May. 24 | The Hydration Pharmaceuticals Company Limited Announces Board Change, Effective 25 May 2024 | CI |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Hydralyte
100.0
%
| 9 | 100.0 % | 10 | 100.0 % | +10.34% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
57.2
%
| 5 | 50.5 % | 6 | 57.2 % | +24.80% |
United States
42.8
%
| 5 | 49.5 % | 4 | 42.8 % | -4.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oliver Baker
CEO | Chief Executive Officer | - | 17-12-31 |
Chris Kavanaugh
DFI | Director of Finance/CFO | - | 18-04-30 |
Victoria Nadalin
SEC | Corporate Secretary | - | 23-02-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Margaret Hardin
BRD | Director/Board Member | 51 | 22-02-07 |
Adem Karafili
CHM | Chairman | - | 18-10-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 265,141,804 | 223,688,259 ( 84.37 %) | 0 | 84.37 % |
Company contact information
The Hydration Pharmaceuticals Co. Ltd.
Level 42 Rialto South Tower
3000, Melbourne
+
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-62.50% | 1.85M | |
+56.89% | 809B | |
+39.52% | 624B | |
-6.55% | 351B | |
+7.92% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 166B | |
-2.57% | 157B |
- Stock Market
- Equities
- HPC Stock
- Company The Hydration Pharmaceuticals Company Limited